Regulator inspection intelligence is software that gathers the findings of drug regulators' inspections of plants around the world, and sorts them by topic. A drug maker uses it to see what inspectors are looking for, before they arrive at its own plant. It is also called regulatory intelligence or inspection analytics.
Here is the background. Drug regulators inspect plants that make medicines. In India, the regulator is CDSCO, together with the state drug controllers. A plant that exports to America is also inspected by the US FDA. The US FDA inspects hundreds of plants in India every few years. At the end of an inspection, the US FDA inspector hands the plant a list of problems found. This list is called a Form 483. If the problems are serious, the FDA later sends a warning letter, which is public. In the worst cases, it can stop the plant's medicines from entering America. This is called an import alert. Many such documents are published, or can be requested from the FDA.
The software collects these documents and others like them. It reads each one, and tags each finding with its topic, such as cleaning, data integrity or laboratory testing. Data integrity means that records are complete, accurate and cannot be changed without a trace. The software also links each finding to the plant, the type of medicine and the inspector. So a quality team can search the findings, like a library.
Imagine a drug maker in Ahmedabad. Its plant makes injectable medicines for export, and it expects a US FDA inspection in three months. Its quality team searches the software for recent inspections of Indian plants that make injectables. The search shows that the most common findings were about clean rooms and about laboratory records that were changed without a reason. It also shows the topics that the expected inspectors have raised most often at other plants. The team then reviews its own records on those topics first. It finds two laboratory tests that were repeated without an explanation. It opens investigations for them in its quality management system (QMS) and fixes the process before the inspection.
Why does this matter? An inspection can decide whether a plant may keep selling its medicines. A warning letter can stop exports from one Indian plant for years. So the plants that export the most watch these findings closely.
The software does not replace the plant's own records or its own GxP compliance. It only helps the plant decide where to look first. The records that inspectors read are those of pharma manufacturing, such as the electronic batch record.
How is this different from a QMS? The QMS holds the plant's own problems and fixes. Inspection intelligence holds other plants' inspection findings, from outside the company. The two are often used together: a finding seen elsewhere becomes a check in the plant's own QMS.